Healthcare & Life Sciences
Candel Therapeutics
United Stateswww.candel.com/
Candel Therapeutics is a Healthcare & Life Sciences startup based in the United States, most recent round Series C+, 1 tracked investor.
series-c-plus
series-c-plus
Stage
1
Investors
About Candel Therapeutics
Based in the United States, Candel Therapeutics is a startup. Its most recent tracked round is Series C+. Brouky classifies it under Healthcare & Life Sciences. Brouky records 1 investor associated with the company.
Candel Therapeutics is a clinical-stage immuno-oncology company developing oncolytic virus therapies that activate the immune system to target and kill cancer cells.
Explore Candel Therapeutics's full profile on Brouky
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.